Development of HIV capsid-targeting antivirals that affect immune response by modulating capsid stability and have improved resistance profiles

Medicine & Life Sciences

1. Capsid 100%
2. HIV-1 67%
3. Antiviral Agents 65%
4. HIV 52%
5. mRNA Cleavage and Polyadenylation Factors 26%
6. Cyclophilin A 22%
7. Nuclear Pore Complex Proteins 22%
8. gag Gene Products 20%
9. Nucleocapsid 20%
10. Life Cycle Stages 18%
11. Capsid Proteins 17%
12. Artifacts 14%
13. Virion 14%
14. Reverse Transcription 13%
15. Viruses 11%
16. Peptides 10%
17. DNA 8%
18. Proteins 5%